pentobarbital will reduce the level or result of gefitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the extent or impact of armodafinil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unknown.
pentobarbital will minimize the level or effect of midazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lower the level or outcome of carvedilol by affecting hepatic enzyme CYP2C9/10 metabolism. Use Warning/Monitor.
pentobarbital will reduce the extent or result of irinotecan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
Monitor Closely (one)pentobarbital will minimize the extent or result of mifepristone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. CYP3A4 inducers have not been studied, coadministration not encouraged by maker
With therapeutic doses of TCAs, barbiturates improve metabolism and reduce blood concentrations of TCAs.
pentobarbital will lessen the extent or impact of dasatinib by website influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital decreases levels of toremifene by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. CYP3A4 inducers maximize amount of toremifene metabolism, reducing the steady-point out concentration in serum.
pentobarbital will lower the extent or influence of cevimeline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unfamiliar.
pentobarbital will decrease the level or impact of alfentanil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Mysterious.
By clicking mail, you acknowledge that you've authorization to e mail the recipient with this facts.
pentobarbital will lessen the extent or effect of nimodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.
pentobarbital will minimize the level or influence of fostemsavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.